Rong Tang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy.

The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy.

Journal: Oncogenesis

Published: January 15, 2026

Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort.

Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort.

Journal: Cancer medicine

Published: November 14, 2025

Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer.

Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 01, 2025

Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer.

Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer.

Journal: Cancer cell

Published: September 16, 2025

m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis.

m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis.

Journal: Cell death & disease

Published: April 23, 2025

Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer.

Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer.

Journal: Nature communications

Published: February 18, 2025

Identification of DNA damage and repair gene-related markers in pancreatic ductal adenocarcinoma by single-cell and bulk RNA sequencing.

Identification of DNA damage and repair gene-related markers in pancreatic ductal adenocarcinoma by single-cell and bulk RNA sequencing.

Journal: Discover oncology

Published: December 02, 2024

Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism.

Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism.

Journal: Gastroenterology

Published: November 11, 2024

Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression.

Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression.

Journal: Biomarker research

Published: November 11, 2024

Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis.

Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis.

Journal: Heliyon

Published: July 26, 2024

TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality.

TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality.

Journal: Gut

Published: May 03, 2024

Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma.

Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinoma.

Journal: Computational and structural biotechnology journal

Published: January 15, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026